Show Friday September 19, 2014

Friday September 19, 2014


See all
Click on the following buttons to choose the program topics that interest you.
By categories
Welcome coffee
Coffee break and visit of the exhibition
Lunch
Gala Dinner


08.00
Welcome coffee
08.15

Introduction

Speaker : P. Métellus
08.30

Basic Science & Translational Research Perspectives

  • 08.30 - Brain metastases preclinical models, P. Steeg, USA
  • 09.00 - Genomic Characterization of Brain Metastases Reveals Branched, Evolution and Metastasis-Specific Mutations, P. Brastianos, USA
  • 09.30 - Brain metastases and methylation profile, C. Geisenberger, DE
  • 10.00 - Circulating tumor cells and brain metastases outcome in HER2-positive breast cancer patients, J-Y. Pierga, FR
Attached file :
10.30
Coffee break and visit of the exhibition
11.00

Integrated Targeted Therapies Strategies (Part 1)

  • 11.00 - Graded prognostic Indices at the age of molecular profiling and targeted therapies, M. Ahluwalia, USA
  • 11.30 - Targeted therapies in BRAF-mutant brain metastatic melanoma patients, C. Mateus, FR
12.00

Integrated Targeted Therapies Strategies (Part 2)

  • 12.00 - Systemic therapy for breast cancer in the brain: future potential, D. Cameron, UK
  • 12.30 - Targeted therapies and brain metastases in lung cancer patients, B. Besse, FR
Attached files :
13.00
Lunch
13.30

Symposium BMS

  • 13.30 - Immuno-Oncology in Brain Metastases Concept of Immuno-Oncology and Immunotherapy on Brain Metastases in lung cancer, F. Barlési - FR
  • 14.00 - Immunotherapy on Brain Metastases un melanoma, S. Monestier-Gasmi - FR
Attached files :
Moderator : JJ. Grob
14.30

Innovative Trial Concepts

  • 14.30 - Innovative trial concepts in Brain Metastases, M. Mehta - USA
  • 15.00 - Window of Opportunity studies in Brain Metastases, J-C. Tönn - DE
Attached files :
Moderators : M. Preusser Z. Ram
15.30

Neuroimaging endpoints in clinical trials

  • 15.30 - Neuroimaging assessment of brain metastases in the targeted therapy era, A. Radbruch, DE
Attached file :
16.00

Neurocognition and QoL Assessment

  • 16.00 - Chemotherapy related cognitive deficits, S. Schagen, NL
  • 16.30 - Neurocognitive assessment in BM, M. Klein, NL
Attached files :
17.00

Symposium Brainlab

Automatic Brain Metastases Planning: Fast Treatment. Focused Dose. Revolutionary Technology.
The biological response of brain metastases to stereotactic radiotherapy, R. Zakaria - UK

17.45

Poster session (with guided poster walks, cheese & wine)

20.00
Gala Dinner
Top